Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture

European Journal of Vascular and Endovascular Surgery

Volumn 20, Issue 5, 2000, Pages 457-461

  Petersen, E ^a   Gineitis, A ^b   Wagberg F ^a   Angquist K A ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Abdominal aortic aneurysm; Matrix metalloproteinases

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM RUPTURE; AORTA; AORTA WALL; ARTERY DIAMETER; ARTICLE; BIOPSY; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVITY; FEMALE; HUMAN; LASER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZYMOGRAPHY;

EID: 0034523223     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2000.1211     Document Type: Article

References (28)

1. Relation of structure to function of the tissue of the wall of blood vessels
2. Adventitial elastolysis is a primary event in aneurysm formation
3. Elastase activity: The role of elastase in aortic aneurysm formation
4. Altered aortic protease and anti-protease activity in patients with ruptured abdominal aortic aneurysms
5. Metalloproteinases in degenerative aortic disease
6. Identification of matrix metalloproteinase-3 (stromolysine-1) and 9 (gelatinase-B) in abdominal aortic aneurysms
7. Matrix metalloproteinases in abdominal aortic aneurysm: Characterisation, purification and their possible sources
8. Role of matrix metalloproteinases in abdominal aortic aneurysms
9. Human 92- and 72-kilodalton type IV collagenases are elastases
10. Activated forms of MMP-2 and MMP-9 in abdominal aortic aneurysms
11. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta
12. Cellular location of matrix metalloproteinases in the abdominal aortic aneurysm wall
13. Inflammation and matrix metalloproteinases in enlarging abdominal aortic aneurysm
14. Size matters. Relationship between MMP-9 expression and aortic diameter
15. The limitations of ultrasound in surveillance of small abdominal aortic aneurysms
16. Electrophoretic analysis of plasminogen activators in polyacrylamid gels containing sodium dodecyl sulfate and copolymerized substrates
17. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
18. Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells
19. Elastin is increased in abdominal aortic aneurysms
20. Modifications of the extracellular matrix of aneurysmal abdominal aortas as a function of their size
21. Matrix metallo-proteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms
22. Chlamydia pneumoniae in human abdominal aortic aneurysms
23. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms: Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms
24. Pathophysiology and pathogenesis of aortic aneurysms. Current concepts
25. Relationship between abdominal aortic aneurysm wall compliance and clinical outcome: A preliminary analysis
26. The amino-terminal propeptide of type III procollagen in follow-up of abdominal aortic aneurysms patients
27. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: Preservation of aortic elastin associated with suppressed production of 92 kD gelatinase
28. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial